- Home
- NBP vs ELMD Comparison
NBP vs ELMD Comparison
Compare NBP & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBP | ELMD |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 208.1M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | NBP | ELMD |
|---|---|---|
| Price | $1.49 | $37.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 646.2K | 62.0K |
| Earning Date | 04-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.55 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $54,716,000.00 |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | ★ N/A | $41.33 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $1.46 | $17.73 |
| 52 Week High | $5.19 | $40.00 |
Technical Indicators
Market Signals| Indicator | NBP | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 26.54 | 61.58 |
| Support Level | N/A | $23.47 |
| Resistance Level | $1.95 | $40.00 |
| Average True Range (ATR) | 0.12 | 2.05 |
| MACD | -0.01 | -0.44 |
| Stochastic Oscillator | 6.19 | 41.80 |
Price Performance
Historical ComparisonAbout NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.